IL155997A0 - Protease inhibitors - Google Patents

Protease inhibitors

Info

Publication number
IL155997A0
IL155997A0 IL15599701A IL15599701A IL155997A0 IL 155997 A0 IL155997 A0 IL 155997A0 IL 15599701 A IL15599701 A IL 15599701A IL 15599701 A IL15599701 A IL 15599701A IL 155997 A0 IL155997 A0 IL 155997A0
Authority
IL
Israel
Prior art keywords
protease inhibitors
protease
inhibitors
Prior art date
Application number
IL15599701A
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL155997A0 publication Critical patent/IL155997A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
IL15599701A 2000-11-22 2001-11-19 Protease inhibitors IL155997A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25250800P 2000-11-22 2000-11-22
PCT/US2001/051647 WO2003053331A2 (en) 2000-11-22 2001-11-19 Protease inhibitors

Publications (1)

Publication Number Publication Date
IL155997A0 true IL155997A0 (en) 2003-12-23

Family

ID=22956303

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15599701A IL155997A0 (en) 2000-11-22 2001-11-19 Protease inhibitors

Country Status (17)

Country Link
EP (1) EP1392657A4 (en)
JP (1) JP2005513083A (en)
KR (1) KR20040004445A (en)
CN (1) CN1635903A (en)
AR (1) AR034278A1 (en)
AU (1) AU2001298052A1 (en)
BR (1) BR0115473A (en)
CA (1) CA2436850A1 (en)
CZ (1) CZ20031403A3 (en)
HU (1) HUP0301964A3 (en)
IL (1) IL155997A0 (en)
MX (1) MXPA03004542A (en)
NO (1) NO20032328L (en)
PL (1) PL366232A1 (en)
UY (1) UY27032A1 (en)
WO (1) WO2003053331A2 (en)
ZA (1) ZA200303848B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
US7071184B2 (en) 2000-03-21 2006-07-04 Smithkline Beecham Corporation Protease inhibitors
NZ522965A (en) * 2000-06-14 2004-06-25 Smithkline Beecham Corp Protease inhibitors
US20110092484A1 (en) 2007-06-08 2011-04-21 Nippon Chemiphar Co., Ltd. Therapeutic or prophylactic agent for cerebral aneurysm
EP2216047A4 (en) 2007-10-24 2011-12-28 Nat Univ Corp Tokyo Med & Dent Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0104768A3 (en) * 1998-12-23 2002-05-28 Smithkline Beecham Corp 4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same
US7071184B2 (en) * 2000-03-21 2006-07-04 Smithkline Beecham Corporation Protease inhibitors
NZ522965A (en) * 2000-06-14 2004-06-25 Smithkline Beecham Corp Protease inhibitors

Also Published As

Publication number Publication date
BR0115473A (en) 2004-09-28
AR034278A1 (en) 2004-02-18
EP1392657A4 (en) 2004-03-10
ZA200303848B (en) 2004-06-28
CN1635903A (en) 2005-07-06
WO2003053331A2 (en) 2003-07-03
WO2003053331A3 (en) 2003-11-13
NO20032328L (en) 2003-07-02
CA2436850A1 (en) 2003-07-03
UY27032A1 (en) 2002-07-31
JP2005513083A (en) 2005-05-12
HUP0301964A2 (en) 2007-02-28
PL366232A1 (en) 2005-01-24
KR20040004445A (en) 2004-01-13
AU2001298052A1 (en) 2003-07-09
NO20032328D0 (en) 2003-05-22
HUP0301964A3 (en) 2007-09-28
EP1392657A2 (en) 2004-03-03
MXPA03004542A (en) 2003-09-10
CZ20031403A3 (en) 2003-10-15

Similar Documents

Publication Publication Date Title
IL150964A0 (en) Protease inhibitors
GB0125445D0 (en) Protease Inhibitors
IL215892A0 (en) Peptidomimetic protease inhibitors
IL153421A0 (en) Protease inhibitors
EP1235577A4 (en) Protease inhibitors
EP1232155A4 (en) Protease inhibitors
IL151087A0 (en) Protease inhibitors
EP1229912A4 (en) Protease inhibitors
EP1231921A4 (en) Protease inhibitors
EP1229915A4 (en) Protease inhibitors
EP1229914A4 (en) Protease inhibitors
HK1043534A1 (en) Protease inhibitors
EP1351930A4 (en) Protease inhibitors
EP1173429A4 (en) Protease inhibitors
EP1233771A4 (en) Protease inhibitors
EP1229911A4 (en) Protease inhibitors
EP1401453A4 (en) Protease inhibitors
EP1231923A4 (en) Protease inhibitors
HUP0301964A2 (en) Protease inhibitors
IL155961A0 (en) Cysteine protease inhibitors
EP1232154A4 (en) Protease inhibitors
EP1231922A4 (en) Protease inhibitors
AU6407701A (en) Serine protease inhibitors
GB0009123D0 (en) Protease inhibitor
ZA200207478B (en) Protease inhibitors.